3M vs Colgate-Palmolive
안전·소비재·헬스케어 제품을 아우르는 글로벌 산업 대기업 vs 글로벌 구강 관리 및 가정용 제품 선도 기업. 9월 2026에 내 포트폴리오에 더 잘 맞는 종목은 무엇일까요? 아래에서 쉽게 설명합니다.
3M generates revenues across industrial, safety, and health care segments with a patent portfolio that took decades to build, while Colgate-Palmolive wrings growth from toothpaste, pet nutrition, and oral health brands sold in nearly every country on earth. Both are mature consumer and industrial franchises where pricing power and cost discipline separate average from excellent. 3M vs Colgate-Palmolive puts two dividend stalwarts head to head on margin recovery, litigation exposure, and organic growth trajectory.
3M generates revenues across industrial, safety, and health care segments with a patent portfolio that took decades to build, while Colgate-Palmolive wrings growth from toothpaste, pet nutrition, and ...
주가 변동 요인
3M is trading on steady execution and an upcoming investor update, not a fresh shock to the story.
- 3M's latest catalyst is a steady flow of operational updates rather than a single game-changing headline, with management recently highlighting a new Cooling Film product and setting up a September 15 investor presentation that could reset expectations for the next leg of the turnaround.
- The company also continues to benefit from its second-quarter results, where stronger organic sales and raised full-year guidance helped reinforce the view that the business is stabilizing after a long restructuring period.
- Recent ex-dividend timing and ongoing dividend payments have kept income-focused investors engaged, while the broader industrial backdrop remains mixed and limits upside enthusiasm in the short term.
Colgate-Palmolive is under pressure as analysts weigh steady earnings against margin headwinds.
- Colgate-Palmolive has been in focus after recent conference appearances and earnings follow-through kept investors focused on growth durability, even as the market weighs softer North American volume trends.
- RBC Capital reiterated its view on the stock in early September, reinforcing the idea that analysts still see the company as defensive but not immune to U.S. consumer pressure.
- The latest commentary around the business has centered on margin pressure from higher raw materials and tariffs in the second half, which is tempering enthusiasm after the company’s solid Q2 top-line performance.
3M is trading on steady execution and an upcoming investor update, not a fresh shock to the story.
- 3M's latest catalyst is a steady flow of operational updates rather than a single game-changing headline, with management recently highlighting a new Cooling Film product and setting up a September 15 investor presentation that could reset expectations for the next leg of the turnaround.
- The company also continues to benefit from its second-quarter results, where stronger organic sales and raised full-year guidance helped reinforce the view that the business is stabilizing after a long restructuring period.
- Recent ex-dividend timing and ongoing dividend payments have kept income-focused investors engaged, while the broader industrial backdrop remains mixed and limits upside enthusiasm in the short term.
Colgate-Palmolive is under pressure as analysts weigh steady earnings against margin headwinds.
- Colgate-Palmolive has been in focus after recent conference appearances and earnings follow-through kept investors focused on growth durability, even as the market weighs softer North American volume trends.
- RBC Capital reiterated its view on the stock in early September, reinforcing the idea that analysts still see the company as defensive but not immune to U.S. consumer pressure.
- The latest commentary around the business has centered on margin pressure from higher raw materials and tariffs in the second half, which is tempering enthusiasm after the company’s solid Q2 top-line performance.
투자 분석
3M
MMM
장점
- 3M has raised its 2025 earnings outlook, reflecting improved profitability and successful execution of its turnaround strategy.
- The company has delivered strong organic sales growth and expanded operating margins, driven by cost controls and a shift towards higher-margin products.
- Recent settlements of long-standing legal issues have reduced uncertainty and cleared the path for future growth and investment.
고려 사항
- Despite recent gains, 3M's valuation scores only moderately on undervaluation metrics, suggesting limited upside potential for new investors.
- The stock has experienced significant volatility, with technical forecasts indicating possible downward pressure in the near term.
- Ongoing restructuring and product mix changes carry execution risks that could affect future performance.
장점
- Colgate-Palmolive maintains a strong global brand presence and consistent demand for its consumer products across multiple categories.
- The company operates with a stable balance sheet and a history of reliable dividend payments, appealing to income-focused investors.
- Colgate-Palmolive benefits from a diversified product portfolio, including oral care, personal care, and pet nutrition segments.
고려 사항
- Revenue growth has been relatively slow, constrained by mature markets and limited pricing power in key regions.
- The company faces increasing competition from private labels and new entrants in the consumer goods sector.
- Exposure to foreign exchange fluctuations and input cost volatility can impact profitability.
3M(MMM) 다음 실적 발표일
The next earnings date for 3M (MMM) is October 20, 2026. The upcoming report is expected to cover Q3 2026. If the company does not confirm the date, it is typically reported in the late-October window based on its historical schedule.
Colgate-Palmolive(CL) 다음 실적 발표일
The next earnings date for CL is expected to be October 30, 2026. This report should cover Q3 2026 results. For Colgate-Palmolive, that timing is consistent with its typical late-October third-quarter earnings pattern.
3M(MMM) 다음 실적 발표일
The next earnings date for 3M (MMM) is October 20, 2026. The upcoming report is expected to cover Q3 2026. If the company does not confirm the date, it is typically reported in the late-October window based on its historical schedule.
Colgate-Palmolive(CL) 다음 실적 발표일
The next earnings date for CL is expected to be October 30, 2026. This report should cover Q3 2026 results. For Colgate-Palmolive, that timing is consistent with its typical late-October third-quarter earnings pattern.
Nemo에서 MMM 또는 CL 매수하기
수수료 무료
주식, ETF 등을 수수료 없이 거래하세요. 수익을 더 많이 지키세요.
신뢰할 수 있는 규제 기관 인가
2015년부터 Exinity Group의 일원으로, 전 세계 100만 명 이상의 고객에게 서비스를 제공합니다.
현금 예치금 6% 이자
투자하지 않은 현금에 연 6%(AER) 이자를 매일 지급합니다.
